Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 01-2012 | 10-2011 | 07-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 11,919 | 17,654 | 19,044 |
| Receivables | 950 | 955 | 1,906 |
| Inventories | 505 | 425 | 528 |
| TOTAL | $13,660 | $19,175 | $21,680 |
| Non-Current Assets | |||
| PPE Net | N/A | 1,874 | 2,031 |
| Other Non-Current Assets | 2,361 | 660 | 660 |
| TOTAL | $2,361 | $2,534 | $2,691 |
| Total Assets | $16,021 | $21,709 | $24,371 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 844 | 1,299 | 1,085 |
| Accrued Expenses | 4,372 | 709 | 804 |
| TOTAL | $5,241 | $2,331 | $2,210 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 35 | 41 | 48 |
| TOTAL | $35 | $41 | $48 |
| Total Liabilities | $5,276 | $2,372 | $2,258 |
| Shareholders' Equity | |||
| Retained earnings | N/A | -102,520 | -98,611 |
| Other shareholders' equity | 10,745 | 12,530 | 11,557 |
| TOTAL | $10,745 | $19,337 | $22,113 |
| Total Liabilities And Equity | $16,021 | $21,709 | $24,371 |